{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:01:20Z","timestamp":1792144880031,"version":"4.4.0"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jns.2020.117252","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T20:37:39Z","timestamp":1606509459000},"page":"117252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch"],"prefix":"10.1016","volume":"420","author":[{"given":"Kenneth","family":"Blum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Lud","family":"Cadet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 9 Suppl 2","key":"10.1016\/j.jns.2020.117252_bb0005","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/MLR.0000000000000731","article-title":"Clinical epidemiology of single versus multiple substance use disorders: polysubstance use disorder","volume":"55","author":"Bhalla","year":"2017","journal-title":"Med. Care"},{"key":"10.1016\/j.jns.2020.117252_bb0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2018.03.039","article-title":"A systematic review of community-based interventions to improve oral chronic disease medication regimen adherence among individuals with substance use disorder","volume":"188","author":"Clements","year":"2018","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.31887\/DCNS.2017.19.3\/hkleber","article-title":"Minding the brain: the role of pharmacotherapy in substance-use disorder treatment","volume":"19","author":"Elias","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.jns.2020.117252_bb0020","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0025","doi-asserted-by":"crossref","first-page":"A10","DOI":"10.1176\/appi.ajp.2018.18121421","article-title":"New findings relevant to substance use disorders","volume":"176","author":"Kalin","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2020.117252_bb0030","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.mcna.2016.03.011","article-title":"Pharmacotherapy for substance use disorders","volume":"100","author":"Klein","year":"2016","journal-title":"Med Clinics North America"},{"key":"10.1016\/j.jns.2020.117252_bb0035","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugalcdep.2018.10.010","article-title":"Conditional probabilities of substance use disorders and associated risk factors: progression from first use to use disorder on alcohol, cannabis, stimulants, sedatives and opioids","volume":"194","author":"Marel","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jfda.2018.09.003","article-title":"Novel technologies in detection, treatment and prevention of substance use disorders","volume":"27","author":"Moulahoum","year":"2019","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.jns.2020.117252_bb0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bcp.2019.07.012","article-title":"Epigenetic pharmacotherapy for substance use disorder","volume":"168","author":"Sartor","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"30","key":"10.1016\/j.jns.2020.117252_bb0050","doi-asserted-by":"crossref","first-page":"E3149","DOI":"10.1073\/pnas.1411228111","article-title":"Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity","volume":"111","author":"Volkow","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.npp.1300515","article-title":"Expression of neural RGS-R7 and G[beta]5 proteins in response to acute and chronic morphine","volume":"30","author":"Lopez-Fando","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.jns.2020.117252_bb0060","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/add.13897","article-title":"Rates, characteristics and circumstances of methamphetamine-related death in Australia: a national 7-year study","volume":"112","author":"Darke","year":"2017","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.jns.2020.117252_bb0065","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.2008.02231.x","article-title":"Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology","volume":"103","author":"Kaye","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.jns.2020.117252_bb0070","series-title":"World drug report 2017","author":"UNODC","year":"2020"},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1520\/JFS14464J","article-title":"Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles","volume":"44","author":"Karch","year":"1999","journal-title":"J. Forensic Sci."},{"issue":"6","key":"10.1016\/j.jns.2020.117252_bb0080","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.drugpo.2012.07.004","article-title":"An evolving problem: methamphetamine production and trafficking in the United States","volume":"23","author":"Shukla","year":"2012","journal-title":"Int. J. Drug Policy"},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/105984050602200202","article-title":"Methamphetamine: putting the brakes on speed","volume":"22","author":"Gettig","year":"2006","journal-title":"J. Sch. Nurs."},{"issue":"11","key":"10.1016\/j.jns.2020.117252_bb0090","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/add.14708","article-title":"Psychostimulant use and the brain","volume":"114","author":"Lappin","year":"2019","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12974-018-1385-0","article-title":"Methamphetamine neurotoxicity, microglia, and neuroinflammation","volume":"15","author":"Shaerzadeh","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.brainresrev.2009.03.002","article-title":"Methamphetamine toxicity and messengers of death","volume":"60","author":"Krasnova","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.jns.2020.117252_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fct.2019.03.035","article-title":"Methamphetamine (\u201ccrystal meth\u201d) causes induction of DNA damage and chromosomal aberrations in human derived cells","volume":"128","author":"Ropek","year":"2019","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1373\/49.1.121","article-title":"Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers","volume":"49","author":"Schepers","year":"2003","journal-title":"Clin. Chem."},{"issue":"7","key":"10.1016\/j.jns.2020.117252_bb0115","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3109\/15563650.2010.516752","article-title":"The clinical toxicology of metamfetamine","volume":"48","author":"Schep","year":"2010","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.jns.2020.117252_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.01.040","article-title":"Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review","volume":"150","author":"Richards","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.jns.2020.117252_bb0125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/dar.13062","article-title":"Methamphetamine use, health and criminal justice system outcomes: a systematic review","volume":"39","author":"Cumming","year":"2020","journal-title":"Drug Alcohol Rev."},{"issue":"6","key":"10.1016\/j.jns.2020.117252_bb0130","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007691-200412000-00013","article-title":"Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans","volume":"26","author":"Kim","year":"2004","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.jns.2020.117252_bb0135","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00008571-200108000-00003","article-title":"Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates","volume":"11","author":"Ramamoorthy","year":"2001","journal-title":"Pharmacogenetics"},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1037\/0033-2909.134.2.301","article-title":"Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications","volume":"134","author":"Homer","year":"2008","journal-title":"Psychol. Bull."},{"issue":"4","key":"10.1016\/j.jns.2020.117252_bb0145","first-page":"214","article-title":"Methamphetamine and the expanding complications of amphetamines","volume":"170","author":"Albertson","year":"1999","journal-title":"West J. Med."},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/00223989809599162","article-title":"Psychophysiological aspects of amphetamine-methamphetamine abuse","volume":"132","author":"Murray","year":"1998","journal-title":"J. Psychol."},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/10673220591003605","article-title":"Implications of chronic methamphetamine use: a literature review","volume":"13","author":"Meredith","year":"2005","journal-title":"Harv Rev Psychiatry"},{"issue":"5","key":"10.1016\/j.jns.2020.117252_bb0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1139\/jpn.0635","article-title":"The need for speed: an update on methamphetamine addiction","volume":"31","author":"Barr","year":"2006","journal-title":"J. Psychiatry Neurosci."},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0165","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11065-007-9031-0","article-title":"Neurocognitive effects of methamphetamine: a critical review and meta-analysis","volume":"17","author":"Scott","year":"2007","journal-title":"Neuropsychol. Rev."},{"issue":"5","key":"10.1016\/j.jns.2020.117252_bb0170","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00414-017-1607-5","article-title":"Medico-legal assessment of methamphetamine and amphetamine serum concentrations-what can we learn from survived intoxications?","volume":"131","author":"Weber","year":"2017","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.jns.2020.117252_bb0175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.forsciint.2018.01.011","article-title":"Disappearance of R\/S-methamphetamine and R\/S-amphetamine from human scalp hair after discontinuation of methamphetamine abuse","volume":"284","author":"Wang","year":"2018","journal-title":"Forensic Sci. Int."},{"issue":"1\u20133","key":"10.1016\/j.jns.2020.117252_bb0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugalcdep.2011.06.013","article-title":"Increased risk of Parkinson\u2019s disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs","volume":"120","author":"Callaghan","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"22","key":"10.1016\/j.jns.2020.117252_bb0185","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1523\/JNEUROSCI.1179-08.2008","article-title":"MS Gold, JL Cadet, Methamphetamine causes microglial activation in the brains of human abusers","volume":"28","author":"Sekine","year":"2008","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0190","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","article-title":"Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases","volume":"87","author":"Smith","year":"2012","journal-title":"Brain Res. Bull."},{"issue":"7","key":"10.1016\/j.jns.2020.117252_bb0195","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1590\/0004-282X20150057","article-title":"Neuroinflammation in the pathophysiology of Parkinson\u2019s disease and therapeutic evidence of anti-inflammatory drugs","volume":"73","author":"Bassani","year":"2015","journal-title":"Arq. Neuropsiquiatr."},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0200","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1742-6723.2005.00735.x","article-title":"Amphetamine-induced movement disorder","volume":"17","author":"Downes","year":"2005","journal-title":"Emerg. Med. Australas"},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0205","first-page":"203","article-title":"Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs","volume":"75","author":"Rylander","year":"1972","journal-title":"Psychiatr. Neurol. Neurochir."},{"key":"10.1016\/j.jns.2020.117252_bb0210","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.neuroscience.2019.03.040","article-title":"Effects of Methamphetamine self-administration and extinction on astrocyte structure and function in the nucleus Accumbens Core","volume":"406","author":"Siemsen","year":"2019","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0215","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/JCP.0000000000000314","article-title":"Effects of acute doses of prosocial drugs methamphetamine and alcohol on plasma oxytocin levels","volume":"35","author":"Bershad","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00213-013-3147-0","article-title":"In the company of others: social factors alter acute alcohol effects","volume":"230","author":"Kirkpatrick","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2020.117252_bb0225","doi-asserted-by":"crossref","first-page":"116733","DOI":"10.1016\/j.jns.2020.116733","article-title":"Molecular neurological correlates of endorphinergic\/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS)","volume":"411","author":"Blum","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0230","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/138920102003190422150527","article-title":"Opioid substitution therapy: achieving harm reduction while searching for a prophylactic solution","volume":"20","author":"Blum","year":"2019","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"9","key":"10.1016\/j.jns.2020.117252_bb0235","article-title":"Psychostimulant drugs for cocaine dependence","volume":"9","author":"Castells","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jns.2020.117252_bb0240","doi-asserted-by":"crossref","first-page":"172671","DOI":"10.1016\/j.ejphar.2019.172671","article-title":"Inhibition of naltrexone on relapse in methamphetamine self-administration and conditioned place preference in rats","volume":"865","author":"Guo","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0245","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/npp.2011.276","article-title":"Is cognitive functioning impaired in methamphetamine users? A critical review","volume":"37","author":"Hart","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0250","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/ejn.13390","article-title":"The dopamine D3 receptor, a quarter century later","volume":"45","author":"Sokoloff","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jns.2020.117252_bb0255","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fpsyt.2018.00603","article-title":"A review of risk factors for Methamphetamine-related psychiatric symptoms","volume":"9","author":"Chang","year":"2018","journal-title":"Front Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0260","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/10550490490436055","article-title":"Psychiatric symptoms in methamphetamine users","volume":"13","author":"Zweben","year":"2004","journal-title":"Am. J. Addict."},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0010-440X(92)90075-2","article-title":"Delusion of parasitosis or chronic tactile hallucinosis: hypothesis about their brain physiopathology","volume":"33","author":"de Leon","year":"1992","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jns.2020.117252_bb0270","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.ento.54.110807.090514","article-title":"Ekbom syndrome: the challenge of \u201cinvisible bug\u201d infestations","volume":"55","author":"Hinkle","year":"2010","journal-title":"Annu. Rev. Entomol."},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0275","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00401-013-1221-7","article-title":"Neuropathology of substance use disorders","volume":"127","author":"JL Cadet","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2020.117252_bb0280","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3389\/fpsyt.2018.00491","article-title":"Comparison of Methamphetamine-induced psychosis and schizophrenia: a review of positive, negative, and cognitive symptomatology","volume":"9","author":"TA Wearne","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jns.2020.117252_bb0285","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3389\/fpsyt.2019.00880","article-title":"Cognition and related neural findings on Methamphetamine use disorder: insights and Treatment implications from schizophrenia research","volume":"10","author":"Guerin","year":"2019","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0290","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/13880209.2019.1651343","article-title":"Long non-coding RNA MEG3 attends to morphine-mediated autophagy of HT22 cells through modulating ERK pathway","volume":"57","author":"Gao","year":"2019","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.jns.2020.117252_bb0295","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jpsychires.2018.09.005","article-title":"Relationship between schizophrenia and changes in the expression of the long non-coding RNAs Meg3, Miat, Neat1 and Neat2","volume":"106","author":"Li","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jns.2020.117252_bb0300","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpsychires.2017.03.005","article-title":"Crack cocaine inhalation induces schizophrenia-like symptoms and molecular alterations in mice prefrontal cortex","volume":"91","author":"LB Areal","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jns.2020.117252_bb0305","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbr.2015.04.036","article-title":"Behavioural, biochemical and molecular changes induced by chronic crack-cocaine inhalation in mice: the role of dopaminergic and endocannabinoid systems in the prefrontal cortex","volume":"290","author":"LB Areal","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jns.2020.117252_bb0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0074-7742(09)88005-7","article-title":"Molecular bases of methamphetamine-induced neurodegeneration","volume":"88","author":"JL Cadet","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0315","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12640-009-9019-z","article-title":"Ocular manifestations of crystal methamphetamine use","volume":"15","author":"Hazin","year":"2009","journal-title":"Neurotox. Res."},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0320","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/1556-4029.13620","article-title":"Clinical characteristics of fatal Methamphetamine-related stroke: a National Study","volume":"63","author":"Darke","year":"2018","journal-title":"J. Forensic Sci."},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0325","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12028-008-9177-5","article-title":"Cerebrovascular complications of methamphetamine abuse","volume":"10","author":"EL Ho","year":"2009","journal-title":"Neurocrit. Care."},{"issue":"4","key":"10.1016\/j.jns.2020.117252_bb0330","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/1742-6723.13219","article-title":"Methamphetamine presentations to an emergency department: management and complications","volume":"31","author":"Isoardi","year":"2019","journal-title":"Emerg. Med. Australas"},{"key":"10.1016\/j.jns.2020.117252_bb0335","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-113-11-821","article-title":"Emergence of recreational drug abuse as a major risk factor for stroke in young adults","volume":"113","author":"Kaku","year":"1990","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"10.1016\/j.jns.2020.117252_bb0340","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/jnnp-2017-316071","article-title":"Stroke and methamphetamine use in young adults: a review","volume":"88","author":"Lappin","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0345","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1520\/JFS16085J","article-title":"Cause and manner of death in fatalities involving methamphetamine","volume":"43","author":"Logan","year":"1998","journal-title":"J. Forensic Sci."},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0350","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0736-4679(99)00009-8","article-title":"Methamphetamine-related stroke: four cases","volume":"17","author":"Perez","year":"1999","journal-title":"J. Emerg. Med."},{"issue":"4","key":"10.1016\/j.jns.2020.117252_bb0355","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archpsyc.64.4.495","article-title":"Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients","volume":"64","author":"Westover","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jns.2020.117252_bb0360","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.4088\/JCP.15m09872","article-title":"Risk of cardiovascular diseases and stroke events in Methamphetamine users: a 10-year follow-up study","volume":"77","author":"Huang","year":"2016","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.jns.2020.117252_bb0365","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/neurintsurg-2014-011161","article-title":"Methamphetamine use is an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage","volume":"7","author":"Moon","year":"2015","journal-title":"J Neurointerv Surg."},{"issue":"4","key":"10.1016\/j.jns.2020.117252_bb0370","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3171\/2012.7.JNS12396","article-title":"The deleterious effects of methamphetamine use on initial presentation and clinical outcomes in aneurysmal subarachnoid hemorrhage","volume":"117","author":"Beadell","year":"2012","journal-title":"J. Neurosurg."},{"issue":"11","key":"10.1016\/j.jns.2020.117252_bb0375","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0046-8177(81)80262-6","article-title":"Amphetamine induced cerebral vasculitis","volume":"12","author":"Bostwick","year":"1981","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0380","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00335049","article-title":"Methamphetamine (\u201cspeed\u201d) arteritis","volume":"2","author":"Margolis","year":"1971","journal-title":"Neuroradiology"},{"issue":"4","key":"10.1016\/j.jns.2020.117252_bb0385","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.38.4.589","article-title":"Ischemic stroke associated with methamphetamine inhalation","volume":"38","author":"Rothrock","year":"1988","journal-title":"Neurology"},{"issue":"1\u20133","key":"10.1016\/j.jns.2020.117252_bb0390","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.forsciint.2012.10.005","article-title":"Methamphetamine and amphetamine concentrations in survivors of body-packer syndrome in Japan","volume":"227","author":"Uekusa","year":"2013","journal-title":"Forensic Sci. Int."},{"issue":"4","key":"10.1016\/j.jns.2020.117252_bb0395","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12024-018-0003-x","article-title":"Rhabdomyolysis observed at forensic autopsy: a series of 52 cases","volume":"14","author":"Hu","year":"2018","journal-title":"Forensic. Sci. Med. Pathol."},{"issue":"12","key":"10.1016\/j.jns.2020.117252_bb0400","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.clinbiochem.2017.02.016","article-title":"Non-traumatic Rhabdomyolysis: background, laboratory features, and acute clinical management","volume":"50","author":"Cervellin","year":"2017","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0405","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pharmthera.2014.05.001","article-title":"Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia","volume":"144","author":"Matsumoto","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0410","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.legalmed.2010.08.007","article-title":"Genetic analysis of the rhabdomyolysis-associated genes in forensic autopsy cases of methamphetamine abusers","volume":"13","author":"Matsusue","year":"2011","journal-title":"Leg Med (Tokyo)"},{"issue":"14","key":"10.1016\/j.jns.2020.117252_bb0415","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/mds.23263","article-title":"Incidence of Parkinson\u2019s disease among hospital patients with methamphetamine-use disorders","volume":"25","author":"Callaghan","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2020.117252_bb0420","series-title":"E.A.H.E.O.N.I.W.m.G.T.M.B. 2008;12:25\u201330., Health economics of nutrigenomics in weight management","first-page":"25","volume":"12","author":"Meshkin","year":"2008"},{"issue":"8","key":"10.1016\/j.jns.2020.117252_bb0425","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/jnnp.44.8.728","article-title":"An extrapyramidal choreiform syndrome caused by amphetamine addiction","volume":"44","author":"Lundh","year":"1981","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2020.117252_bb0430","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0091-3057(81)80018-4","article-title":"Psychopathology induced by \u201cspeed drugs\u201d","volume":"14","author":"Schiorring","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0435","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.26121","article-title":"Behavioral effects of levodopa","volume":"30","author":"Beaulieu-Boire","year":"2015","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0440","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0735-6757(88)90050-2","article-title":"Choreoathetoid disorder associated with amphetamine-like drugs","volume":"6","author":"Rhee","year":"1988","journal-title":"Am. J. Emerg. Med."},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0445","doi-asserted-by":"crossref","first-page":"14","DOI":"10.17756\/jrdsas.2016-023","article-title":"Hypothesizing that, a pro-dopamine regulator (KB220Z) should optimize, but not hyper-activate the activity of trace amine-associated receptor 1 (TAAR-1) and induce anti-craving of Psychostimulants in the long-term","volume":"2","author":"Blum","year":"2016","journal-title":"J. Reward Defic. Syndr. Addict. Sci."},{"issue":"16","key":"10.1016\/j.jns.2020.117252_bb0450","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1073\/pnas.151105198","article-title":"Trace amines: identification of a family of mammalian G protein-coupled receptors","volume":"98","author":"Borowsky","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5\u20136","key":"10.1016\/j.jns.2020.117252_bb0455","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pneurobio.2006.07.003","article-title":"The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain","volume":"79","author":"Burchett","year":"2006","journal-title":"Prog. Neurobiol."},{"issue":"5","key":"10.1016\/j.jns.2020.117252_bb0460","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/mp.2012.57","article-title":"A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight","volume":"18","author":"Revel","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jns.2020.117252_bb0465","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ejphar.2015.06.019","article-title":"Trace amine-associated receptor 1: a promising target for the treatment of psychostimulant addiction","volume":"761","author":"Jing","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.jns.2020.117252_bb0470","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biopsych.2012.05.014","article-title":"Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics","volume":"72","author":"Revel","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"47","key":"10.1016\/j.jns.2020.117252_bb0475","doi-asserted-by":"crossref","first-page":"20081","DOI":"10.1073\/pnas.0906522106","article-title":"The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system","volume":"106","author":"Bradaia","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.jns.2020.117252_bb0480","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bcp.2009.05.031","article-title":"Trace amine-associated receptor 1 as a monoaminergic modulator in brain","volume":"78","author":"Xie","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0485","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/138161212798919110","article-title":"\u201cLiking\u201d and \u201cwanting\u201d linked to reward deficiency syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry","volume":"18","author":"Blum","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0490","first-page":"1","article-title":"Americas\u2019 opioid\/psychostimulant epidemic would benefit from general population early identification of genetic addiction risk especially in children of alcoholics (COAs)","volume":"5","author":"Blum","year":"2019","journal-title":"J. Syst. Integr. Neurosci."},{"issue":"8","key":"10.1016\/j.jns.2020.117252_bb0495","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1601-183X.2009.00522.x","article-title":"Genetically correlated effects of selective breeding for high and low methamphetamine consumption","volume":"8","author":"Wheeler","year":"2009","journal-title":"Genes Brain Behav."},{"issue":"7","key":"10.1016\/j.jns.2020.117252_bb0500","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.neuropharm.2008.07.030","article-title":"Long-term alterations in vulnerability to addiction to drugs of abuse and in brain gene expression after early life ethanol exposure","volume":"55","author":"Barbier","year":"2008","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0505","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s11064-016-2137-0","article-title":"Glutamate and brain Glutaminases in drug addiction","volume":"42","author":"M\u00e1rquez","year":"2017","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.jns.2020.117252_bb0510","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00213-011-2418-x","article-title":"Cocaine modulates both glutaminase gene expression and glutaminase activity in the brain of cocaine-sensitized mice","volume":"219","author":"Blanco","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2020.117252_bb0515","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbr.2015.10.026","article-title":"GABAergic mRNA expression is upregulated in the prefrontal cortex of rats sensitized to methamphetamine","volume":"297","author":"TA Wearne","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FBP.0b013e3283242f05","article-title":"Genetics of dopamine receptors and drug addiction: a comprehensive review","volume":"20","author":"Le Foll","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.jns.2020.117252_bb0525","first-page":"e12840","article-title":"Moratalla, Behavioral sensitization and cellular responses to psychostimulants are reduced in D2R knockout mice","author":"Sol\u00eds","year":"2019","journal-title":"Addict. Biol."},{"issue":"13","key":"10.1016\/j.jns.2020.117252_bb0530","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1038\/npp.2008.126","article-title":"Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence","volume":"33","author":"FW Lohoff","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0535","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0376-8716(93)90113-5","article-title":"Allelic association of the D2 dopamine receptor gene with cocaine dependence","volume":"33","author":"Noble","year":"1993","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jns.2020.117252_bb0540","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3389\/fnins.2019.01392","article-title":"Escalated oxycodone self-administration and punishment: differential expression of opioid receptors and immediate early genes in the rat dorsal striatum and prefrontal cortex","volume":"13","author":"Blackwood","year":"2019","journal-title":"Front. Neurosci."},{"issue":"8","key":"10.1016\/j.jns.2020.117252_bb0545","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1601-183X.2009.00525.x","article-title":"A major QTL on chromosome 11 influences psychostimulant and opioid sensitivity in mice","volume":"8","author":"Bryant","year":"2009","journal-title":"Genes Brain Behav."},{"issue":"4","key":"10.1016\/j.jns.2020.117252_bb0550","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","article-title":"Bozarth, a psychomotor stimulant theory of addiction","volume":"94","author":"RA Wise","year":"1987","journal-title":"Psychol. Rev."},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0555","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1523\/JNEUROSCI.04-01-00111.1984","article-title":"DARPP-32, a dopamine- and adenosine 3\u2032:5\u2032-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization","volume":"4","author":"Ouimet","year":"1984","journal-title":"J. Neurosci."},{"issue":"5378","key":"10.1016\/j.jns.2020.117252_bb0560","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1126\/science.281.5378.838","article-title":"DARPP-32: regulator of the efficacy of dopaminergic neurotransmission","volume":"281","author":"AA Fienberg","year":"1998","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.jns.2020.117252_bb0565","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/sj.npp.1301321","article-title":"Activation of the cAMP\/PKA\/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward","volume":"32","author":"Borgkvist","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0570","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1556\/2006.2020.00033","article-title":"Co-occurrences of substance use and other potentially addictive behaviors: epidemiological results from the psychological and genetic factors of the addictive Behaviors (PGA) study","volume":"9","author":"Kotyuk","year":"2020","journal-title":"J. Behav. Addict."},{"key":"10.1016\/j.jns.2020.117252_bb0575","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuint.2018.12.004","article-title":"Expression of immediate early genes in brain reward circuitries: differential regulation by psychostimulant and opioid drugs","volume":"124","author":"Bisagno","year":"2019","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0580","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1601-183X.2010.00655.x","article-title":"OPRM1 gene variants modulate amphetamine-induced euphoria in humans","volume":"10","author":"Dlugos","year":"2011","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.jns.2020.117252_bb0585","first-page":"189","article-title":"Neuropsychological consequences of chronic drug use: relevance to Treatment approaches","volume":"6","author":"JL Cadet","year":"2015","journal-title":"Front Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0590","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00213-008-1408-0","article-title":"Prospective memory impairment in former users of methamphetamine","volume":"203","author":"Rendell","year":"2009","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.jns.2020.117252_bb0595","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0028-3932(02)00015-5","article-title":"Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences","volume":"40","author":"Bechara","year":"2002","journal-title":"Neuropsychologia"},{"issue":"7","key":"10.1016\/j.jns.2020.117252_bb0600","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1517\/14712598.2015.1045871","article-title":"Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the promised land?","volume":"15","author":"Blum","year":"2015","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"7","key":"10.1016\/j.jns.2020.117252_bb0605","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/syn.20523","article-title":"D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats","volume":"62","author":"Thanos","year":"2008","journal-title":"Synapse (New York, N.Y.)"},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0610","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0149-7634(85)90022-3","article-title":"New concepts in cocaine addiction: the dopamine depletion hypothesis","volume":"9","author":"Dackis","year":"1985","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.jns.2020.117252_bb0615","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jinsphys.2010.03.014","article-title":"Dopamine down-regulates activity of alkaline phosphatase in drosophila: the role of D2-like receptors","volume":"56","author":"Bogomolova","year":"2010","journal-title":"J. Insect Physiol."},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0620","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/02791072.1990.10472542","article-title":"Neurodynamics of relapse prevention: a neuronutrient approach to outpatient DUI offenders","volume":"22","author":"Brown","year":"1990","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.jns.2020.117252_bb0625","first-page":"1204","article-title":"Reduction of both drug hunger and withdrawal against advice rate of cocaine abusers in a 30 day in-patient treatment program by the neuronutrient Tropamine","volume":"43","author":"Blum","year":"1988","journal-title":"Curr. Ther. Res."},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00044011-199612010-00001","article-title":"JA, NeuRecover-SATM in the Treatment of cocaine withdrawal and craving: a pilot study","volume":"12","author":"Cold","year":"1996","journal-title":"Clin. Drug Investig."},{"issue":"6","key":"10.1016\/j.jns.2020.117252_bb0635","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3810\/pgm.2010.11.2237","article-title":"Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D(2) agonist therapy: part 2","volume":"122","author":"Blum","year":"2010","journal-title":"Postgrad. Med."},{"issue":"6","key":"10.1016\/j.jns.2020.117252_bb0640","doi-asserted-by":"crossref","DOI":"10.15761\/JSIN.1000183","article-title":"\u201cDopamine homeostasis\u201d requires balanced polypharmacy: issue with destructive, powerful dopamine agents to combat America\u2019s drug epidemic","volume":"3","author":"Blum","year":"2017","journal-title":"J. Syst. Integr. Neurosci."},{"issue":"4","key":"10.1016\/j.jns.2020.117252_bb0645","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.conb.2013.01.002","article-title":"Unbalanced neuronal circuits in addiction","volume":"23","author":"Volkow","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0650","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/dar.12414","article-title":"A potential role for N-acetylcysteine in the management of methamphetamine dependence","volume":"36","author":"McKetin","year":"2017","journal-title":"Drug Alcohol Rev."},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0655","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S1461145712000661","article-title":"Modification of cocaine self-administration by buspirone (buspar\u00ae): potential involvement of D3 and D4 dopamine receptors","volume":"16","author":"Bergman","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.jns.2020.117252_bb0660","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.biopsych.2012.07.011","article-title":"Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine \u03b2-hydroxylase","volume":"73","author":"Kosten","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0665","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00213-017-4776-5","article-title":"N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges","volume":"235","author":"Swanepoel","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2020.117252_bb0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2017.12.009","article-title":"Repeated methamphetamine and modafinil induce differential cognitive effects and specific histone acetylation and DNA methylation profiles in the mouse medial prefrontal cortex","volume":"82","author":"Gonz\u00e1lez","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jns.2020.117252_bb0675","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fnins.2020.00137","article-title":"rTMS-induced changes in Glutamatergic and dopaminergic systems: relevance to cocaine and Methamphetamine use disorders","volume":"14","author":"Moretti","year":"2020","journal-title":"Front. Neurosci."},{"issue":"9","key":"10.1016\/j.jns.2020.117252_bb0680","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1517\/14712598.2014.920319","article-title":"The future potential for cocaine vaccines","volume":"14","author":"Orson","year":"2014","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"6","key":"10.1016\/j.jns.2020.117252_bb0685","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.ejmech.2010.02.004","article-title":"A molecular model for cocaine binding by the immunotherapeutic human\/mouse chimeric monoclonal antibody 2E2","volume":"45","author":"Lape","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.jns.2020.117252_bb0690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138959","article-title":"Correction: the anti-(+)-Methamphetamine monoclonal antibody mAb7F9 attenuates acute (+)-Methamphetamine effects on intracranial self-stimulation in rats","volume":"10","author":"Harris","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2020.117252_bb0695","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3389\/fpsyt.2019.00621","article-title":"rTMS stimulation group. rTMS Reduces psychopathological burden and cocaine consumption in treatment-seeking subjects with cocaine use disorder: An open label, Feasibility Study","volume":"10","author":"Pettorruso","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jns.2020.117252_bb0700","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3389\/fnins.2019.01095","article-title":"Effects of non-invasive brain stimulation on stimulant craving in users of cocaine, amphetamine, or methamphetamine: a systematic review and meta-analysis","volume":"13","author":"Ma","year":"2019","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0705","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/02791072.1990.10472542","article-title":"Neurodynamics of relapse prevention: a neuronutrient approach to outpatient DUI offenders","volume":"22","author":"Brown","year":"1990","journal-title":"J. Psychoactive Drugs"},{"issue":"6","key":"10.1016\/j.jns.2020.117252_bb0710","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3810\/pgm.2010.11.2237","article-title":"Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D\u2082 agonist therapy: part 2","volume":"122","author":"Blum","year":"2010","journal-title":"Postgrad. Med."},{"issue":"6","key":"10.1016\/j.jns.2020.117252_bb0715","first-page":"1204","article-title":"Reduction of both drug hunger and withdrawal against advice rate of cocaine abusers in a 30-day in-patient treatment program by the neuronutrient Tropamine","volume":"43","author":"Blum","year":"1988","journal-title":"Curr. Ther. Res."},{"issue":"1","key":"10.1016\/j.jns.2020.117252_bb0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00044011-199612010-00001","article-title":"NeuRecover-SATM in the treatment of cocaine withdrawal and craving: a pilot study","volume":"12","author":"Cold","year":"1996","journal-title":"Clin Drug Investig."},{"key":"10.1016\/j.jns.2020.117252_bb0725","doi-asserted-by":"crossref","first-page":"112563","DOI":"10.1016\/j.bbr.2020.112563","article-title":"Administration of a putative pro-dopamine regulator, a neuronutrient, mitigates alcohol intake in alcohol-preferring rats","volume":"385","author":"Solanki","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.jns.2020.117252_bb0730","first-page":"01","article-title":"Pro-dopamine regulator (KB220) a fifty year sojourn to combat reward deficiency syndrome (RDS): evidence based bibliography (annotated)","volume":"1","author":"Blum","year":"2018","journal-title":"CPQ Neurol. Psycol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20305888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20305888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:52:17Z","timestamp":1758383537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20305888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":146,"alternative-id":["S0022510X20305888"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.117252","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.117252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117252"}}